MRNA241115C44000
- 0.01
- 0.000.00%
Moderna Newsroom
BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho
The annual "big reshuffling" of the Nasdaq 100 is about to begin! Who is expected to join, and who will be eliminated?
This year's potential high-flying stocks like palantir, MSTR and more are expected to be included.
Moderna Opens Southern Hemisphere's Only MRNA Manufacturing Facility in Victoria
Moderna, Inc. (MRNA) 7th Annual Evercore ISI HealthCONx Conference - (Transcript)
Moderna Shares Could Slump Over 30% on Negative CMV Reading: Leerink
Palantir, MicroStrategy Lead List of Stocks That Could Join Nasdaq 100
Moderna, Inc. (MRNA): A Bull Case Theory
Moderna Options Spot-On: On November 27th, 118.24K Contracts Were Traded, With 656.81K Open Interest
On November 27th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 118.24K options for the day, of which put options accounted for 60.68% of the total transactions,
Which Is a Better Buy: Moderna or Pfizer?
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Bird Flu Found In Raw Milk Leads To Recall In California
Moderna Analyst Ratings
Moderna, Inc. (MRNA): An Oversold Healthcare Stock to Invest In Now
Moderna's Shares Surge Amid Promising Vaccine Developments and Strategic Partnerships
JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating
Express News | JPMorgan lowered moderna's target price from $59 to $45.
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
Express News | Corrected-Buzz-U.S. Stocks on the Move-AMC, Alnylam, Super Micro
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday